Oxygen Cylinders and Concentrators Market Size & Share, by Product (Portable, Fixed); Application - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

Oxygen Cylinders and Concentrators Industry - Regional Synopsis

North America Market Analysis

North America oxygen cylinders and concentrators market is expected to capture revenue share of over 40.8% by 2037. The heavy use of oxygen in patient-care units is driving the propagation of this merchandise. Thus, the strong healthcare infrastructure in this region, particularly in high-income countries such as the U.S. and Canada, is accommodating their facilities with maximum O2 resources. This creates a stable distribution channel for this sector, inspiring foreign and local pioneers to expand their reach across this landscape. For instance, in April 2024, Dynarex Corporation its innovative respiratory therapy portfolio with the launch of a new portable products suite, Dynarex Resp-O2.

The U.S. is propagating the oxygen cylinders and concentrators market with its inflating medical expenditure and economic growth. In addition, the presence of a supportive regulatory framework promotes innovation and great revenue generation in this field. For instance, in February 2022, Belluscura, a global leader in portable oxygen enrichment technology, shared its financial and commercial escalation after getting 510(k) clearance from the FDA for its X-PLO2R. The company highlighted 377 units of purchases within 1 month after its launch in the U.S. marketplace. This is encouraging more sustainable industrial assets to join this cohort. On this note, in June 2024, Air Liquide invested USD 850.0 million to establish low-carbon ASUs in the U.S. to solidify its industrial merchandise.

Canada is also strengthening the nationwide medical system with notable investments in the oxygen cylinders and concentrators market. The country is facing an outbreak of pulmonary fibrosis, which demands continuous oxygen therapy to keep the patient alive. A CPFF 2022 Patient and Caregiver Survey exposed that over 30,000 citizens from around the nation suffer from this disease, highlighting the critical importance of continuous oxygen supply and access. The country is also following the path of sustainability while increasing access to medical O2 in resource-constrained areas. Moreover, the desperate efforts from several public and private health organizations to mitigate the disparity in availing of sufficient sources are fueling demand in this sector.

APAC Market Statistics

Asia Pacific is projected to register the fastest growth in the oxygen cylinders and concentrators market during the assessed period. There is a combined force of drivers, including the elderly population, the prevalence of hypoxemia, and government funds, pushing the region’s progress in this sector forward. In this, regard, international collaborations are playing a crucial role in empowering public access to medical oxygen in resource-constrained regions. For instance, in April 2023, the consortium of the Vanuatu Ministry of Health, WHO, and the European Union shared their plans to establish a new oxygen plant in Vanuatu, Oceania. They aimed at producing over 500,000 liters of medicinal oxygen within 24 hours, filling 74 cylinders of 6800-liter capacity.

Pioneers in the India oxygen cylinders and concentrators market are proactively compensating for the disparities in public access by enabling advanced technology and convenience through their offerings. During and after the pandemic strike, the country realized the importance of cultivating local supply channels to combat emergencies. On this note, in April 2021, Exalta launched a mini portable water-based pure O2 concentrator, with utility in both commercial and domestic scenarios, delivering a 1-8 liters/minute flow. The dynamics also propelled the business pace for other suppliers. For instance, in January 2022, the Uttar Pradesh Medical Supplies Corporation opted for Servotech to ensure adequate Oxygen provision during the COVID-19 crisis.

China is also securing its proprietorship in the regional oxygen cylinders and concentrators market by utilizing its exceptional manufacturing capabilities. The country’s strong emphasis on this field is testified by the rapid extension in domestic medical device production and exploration. According to the International Trade Administration, the medical device industry in China is projected to adhere to an 8.3% CAGR during the period between 2021 and 2026. It further estimated the value to be at USD 48.8 billion by 2026. Furthermore, the nationwide awareness campaigns and government initiatives are positively influencing this merchandise while affiliating it with continuous capital influx.